By Aaron Vehling ( June 20, 2014, 9:02 PM EDT) -- Two generic-drug makers have asked the high court to decline to review a Federal Circuit decision nixing a drug patent, saying the appeals court correctly found that Pronova BioPharma Norge AS triggered a statutory bar that invalidates technology patents if they are in "public use" for over a year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.